Alpha Tau Medical Ltd. announced the successful treatment of the first immunocompromised patient with recurrent cutaneous squamous cell carcinoma in its ADMIRE study at Banner MD Anderson Cancer Center in Arizona. The company is a developer of photo-immunotherapy technology for own-purpose use in oncology.
